Answers are grounded in this paper and cite their sources.
Magnetic resonance imaging techniques measuring CBF have developed rapidly in the last decade, resulting in a wide range of available methods. The most successful approaches are based either on dynamic tracking of a bolus of a paramagnetic contrast agent (dynamic susceptibility contrast) or on arterial spin labeling. This review discusses their principles, possible pitfalls, and potential for absolute quantification and outlines clinical and neuroscientific applications.
No takes yet. Share an insight, caveat, or question.
Calamante et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: